Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1934 1
1956 1
1957 2
1958 1
1959 1
1965 1
1966 3
1967 2
1968 4
1969 4
1970 1
1971 1
1974 1
1975 1
1976 1
1977 1
1980 2
1981 2
1982 1
1985 3
1986 5
1987 1
1988 3
1989 2
1990 2
1991 3
1992 2
1993 1
1994 4
1995 10
1996 15
1997 14
1998 11
1999 10
2000 13
2001 9
2002 4
2003 8
2004 7
2005 10
2006 13
2007 13
2008 10
2009 7
2010 2
2011 1
2013 2
2014 2
2015 1
2016 3
2017 1
2018 3
2019 3
2020 2
2021 3
2022 1
2024 3
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

235 results

Results by year

Filters applied: . Clear all
Page 1
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study.
Adams D, Polydefkis M, González-Duarte A, Wixner J, Kristen AV, Schmidt HH, Berk JL, Losada López IA, Dispenzieri A, Quan D, Conceição IM, Slama MS, Gillmore JD, Kyriakides T, Ajroud-Driss S, Waddington-Cruz M, Mezei MM, Planté-Bordeneuve V, Attarian S, Mauricio E, Brannagan TH 3rd, Ueda M, Aldinc E, Wang JJ, White MT, Vest J, Berber E, Sweetser MT, Coelho T; patisiran Global OLE study group. Adams D, et al. Lancet Neurol. 2021 Jan;20(1):49-59. doi: 10.1016/S1474-4422(20)30368-9. Epub 2020 Nov 16. Lancet Neurol. 2021. PMID: 33212063 Free article. Clinical Trial.
Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy: A Randomized Clinical Trial With Open-Label Extension.
Adams D, Wixner J, Polydefkis M, Berk JL, Conceição IM, Dispenzieri A, Peltier A, Ueda M, Bender S, Capocelli K, Jay PY, Yureneva E, Obici L; patisiran Global OLE study group. Adams D, et al. JAMA Neurol. 2025 Mar 1;82(3):228-236. doi: 10.1001/jamaneurol.2024.4631. JAMA Neurol. 2025. PMID: 39804640 Free PMC article. Clinical Trial.
Climate Change and Health.
Crowley RA, Moyer DV, DeLong DM. Crowley RA, et al. Among authors: delong dm. Ann Intern Med. 2016 Nov 15;165(10):747-748. doi: 10.7326/L16-0411. Ann Intern Med. 2016. PMID: 27842409 No abstract available.
Comparing risk-adjustment methods for provider profiling.
DeLong ER, Peterson ED, DeLong DM, Muhlbaier LH, Hackett S, Mark DB. DeLong ER, et al. Among authors: delong dm. Stat Med. 1997 Dec 15;16(23):2645-64. doi: 10.1002/(sici)1097-0258(19971215)16:23<2645::aid-sim696>3.0.co;2-d. Stat Med. 1997. PMID: 9421867 Review.
Reducing Disparities in Access to Kidney Transplantation Regional Study: A Randomized Trial in the Southeastern United States.
Patzer RE, Buford J, Urbanski M, McPherson L, Paul S, Di M, Harding JL, Katz-Greenberg G, Rossi A, Anand PM, Reeves-Daniel A, Jones H, Mulloy L, Pastan SO; Southeastern Kidney Transplant Coalition. Patzer RE, et al. Clin J Am Soc Nephrol. 2024 Dec 13;20(2):256-66. doi: 10.2215/CJN.0000000586. Online ahead of print. Clin J Am Soc Nephrol. 2024. PMID: 39671258
Mycophenolic acid: antiviral and antitumor properties.
Williams RH, Lively DH, DeLong DC, Cline JC, Sweeny MJ. Williams RH, et al. Among authors: delong dc. J Antibiot (Tokyo). 1968 Jul;21(7):463-4. doi: 10.7164/antibiotics.21.463. J Antibiot (Tokyo). 1968. PMID: 4303502 Free article. No abstract available.
235 results